RIGScan CR49 radiolabel targeting with a hand-held gamma probe: Completed Phase III trials in the U.S. and Europe, with a PLA expected to be filed in the U.S. b

Neoprobe Corp. (NEOP), Dublin, Ohio Product: RIGScan CR49 radiolabel targeting with a hand-held gamma probe Indication: Surgical detection of metastasized colorectal cancer Status: Completed Phase II...